Related Experiment Video
Updated: Jan 1, 2026

07:31
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
12.2K
MOSFET dosimeter characterization in MR-guided radiation therapy (MRgRT) Linac.
Poonam Yadav1, Abdelbasset Hallil2, Dinesh Tewatia1
1Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, USA.
Journal of Applied Clinical Medical Physics
|December 20, 2019
Summary
Metal-oxide-semiconductor field-effect transistor (MOSFET) dosimeters are unaffected by the 0.345 T magnetic field in MR-guided radiation therapy (MRgRT) systems. These dosimeters demonstrate performance comparable to ionization chambers and thermoluminescent detectors for real-time in-vivo dosimetry.
Area of Science:
- Medical Physics
- Radiation Oncology
- Dosimetry
Background:
- Magnetic Resonance-guided Radiation Therapy (MRgRT) systems integrate magnetic fields with radiation delivery.
- Accurate dosimetry is crucial for patient safety and treatment efficacy in MRgRT.
- The performance of medical dosimeters within strong magnetic fields requires thorough characterization.
Purpose of the Study:
- To characterize the performance of metal-oxide-semiconductor field-effect transistor (MOSFET) dosimeters in a 0.345 T magnetic field relevant to MRgRT.
- To evaluate the accuracy and reliability of MOSFETs for in-vivo dosimetry during MRgRT procedures.
Main Methods:
- A commercial MOSFET dosimetry system was commissioned on an MRIdian MRgRT system.
- Key dosimetric parameters including calibration, linearity, angular dependence, field size dependence, percentage depth dose (PDD), and output factors were assessed.
- Intensity modulated radiation therapy (IMRT) quality assurance (QA) was performed and compared with ionization chamber measurements.
Main Results:
- MOSFET measurements showed no significant impact from the 0.345 T magnetic field, with variations less than 2% in calibration factors.
- Excellent linearity (R² = 0.999) was observed for a wide range of monitor units.
- MOSFET PDD and output factor measurements were in close agreement with ionization chamber data (within 1% and 2.2%, respectively).
- IMRT QA results demonstrated good agreement between MOSFET and ionization chamber measurements across different treatment sites.
Conclusions:
- MOSFET dosimeters are suitable for use in 0.345 T MRgRT systems without magnetic field interference.
- Their performance characteristics are comparable to established dosimetry methods like ionization chambers and thermoluminescent detectors (TLDs).
- MOSFETs offer a viable alternative for real-time in-vivo dosimetry in MRgRT applications.

